trial - International Biopharmaceutical Industry

news

Trial setback casts doubt on a biotech’s respiratory virus drug

Dive Brief: Enanta Pharmaceuticals’ pill to combat respiratory syncytial virus didn’t work in low-risk patients, with the company reporting Wednesday the antiviral...

22 May 2022 news Biotech | Drug

Continue Reading →

news

Lilly’s closely watched diabetes drug scores in obesity trial

Dive Brief: Eli Lilly’s experimental diabetes shot tirzepatide helped obese people who have an underlying medical condition lose more than 15% of their body weight...

29 April 2022 news diabetes | Drug

Continue Reading →

news

Kodiak crashes on negative trial results for would-be Eylea competitor

Dive Brief: Shares in Kodiak Sciences plummeted by 80% in Wednesday morning trading, erasing about $2 billion in market value, after the biotech company's experime...

24 February 2022 news Eylea | Kodiak

Continue Reading →

news

Pressure rises as Gilead awaits important study results for top cancer drug

Gilead lost several billion dollars in market value Wednesday after unnerving investors with updates about a key clinical trial of its most closely watched breast can...

10 February 2022 news cancer | clinical

Continue Reading →

news

Cannabics Pharma clinches clinical trial on Cannabics SR 5mg for CACS

The company is awaiting for the results and expect them to further clarify an important part of their mission in integrating cannabinoid-based therapies into the wo...

6 July 2018 news CACS | cannabics

Continue Reading →

Current Edition

Upcoming Events

Advertisement

Trial setback casts doubt on a biotech’s respiratory virus drug

Lilly’s closely watched diabetes drug scores in obesity trial

Kodiak crashes on negative trial results for would-be Eylea competitor

Pressure rises as Gilead awaits important study results for top cancer drug

Cannabics Pharma clinches clinical trial on Cannabics SR 5mg for CACS

International Biopharmaceutical Industry